Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study
Titel:
Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study
Auteur:
Vogelzang, Nicholas J. Olsen, Mark R. McFarlane, Joshua J. Arrowsmith, Edward Bauer, Todd M. Jain, Rohit K. Somer, Bradley Lam, Elaine T. Kochenderfer, Mark D. Molina, Ana Doshi, Gurjyot Lingerfelt, Brian Hauke, Ralph J. Gunuganti, Vijay Schnadig, Ian Van Veldhuizen, Peter Fleming, Mark Galamaga, Robert Gupta, Mukul Hool, Hugo Hutson, Thomas Zhang, Joshua McHenry, M. Brent Johansen, Jennifer L. Tykodi, Scott S.